drugset / Trial / NCT00158899
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical research study is to compare up to 3 doses of an investigational drug GW501516 to placebo (an inactive pill that looks like GW501516) to see if it is safe, well tolerated and effective in improving (raising) low levels of "good cholesterol", high-density lipoprotein cholesterol (HDLc), as compared to placebo.
Timeline
- Start
- 2004-08
- Primary completion
- 2006-06
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW501516 | Small molecule | 2.5 mg | Oral |
| Subject | GW501516 | Small molecule | 5 mg | Oral |
| Subject | GW501516 | Small molecule | 10 mg | Oral |